XTL-002: Began Phase I trials

(HBV results, B15)

XTL Biopharmaceuticals Ltd.

Read the full 60 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE